Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Software Tools to Facilitate Systematic Review Used for Cancer Hazard Identification.

Shapiro AJ, Antoni S, Guyton KZ, Lunn RM, Loomis D, Rusyn I, Jahnke GD, Schwingl PJ, Mehta SS, Addington J, Guha N.

Environ Health Perspect. 2018 Oct;126(10):104501. doi: 10.1289/EHP4224.

2.

A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuse.

Böhning D, Böhning W, Guha N, Cowan DA, Bartlett C, Sönksen PH, Holt RIG.

BMC Res Notes. 2018 Sep 5;11(1):650. doi: 10.1186/s13104-018-3741-7.

3.

Identifying occupational carcinogens: an update from the IARC Monographs.

Loomis D, Guha N, Hall AL, Straif K.

Occup Environ Med. 2018 Aug;75(8):593-603. doi: 10.1136/oemed-2017-104944. Epub 2018 May 16. Review.

4.

Coffee Drinking and the Risk of Endometrial Cancer: An Updated Meta-Analysis of Observational Studies.

Lukic M, Guha N, Licaj I, van den Brandt PA, Stayner LT, Tavani A, Weiderpass E.

Nutr Cancer. 2018 May-Jun;70(4):513-528. doi: 10.1080/01635581.2018.1460681. Epub 2018 Apr 30.

PMID:
29708405
5.

Cancer mortality in an international cohort of reinforced plastics workers exposed to styrene: a reanalysis.

Loomis D, Guha N, Kogevinas M, Fontana V, Gennaro V, Kolstad HA, McElvenny DM, Sallmén M, Saracci R.

Occup Environ Med. 2018 Apr 17. pii: oemed-2018-105131. doi: 10.1136/oemed-2018-105131. [Epub ahead of print]

6.

The IARC Perspective on Colorectal Cancer Screening.

Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K; International Agency for Research on Cancer Handbook Working Group.

N Engl J Med. 2018 May 3;378(18):1734-1740. doi: 10.1056/NEJMsr1714643. Epub 2018 Mar 26. No abstract available.

7.

Neurocognitive deficits in older patients with cancer.

Edwards BJ, Zhang X, Sun M, Holmes HM, Ketonen L, Guha N, Khalil P, Song J, Kesler S, Shah JB, Tripathy D, Valero V, Champlin RE.

J Geriatr Oncol. 2018 Sep;9(5):482-487. doi: 10.1016/j.jgo.2018.02.010. Epub 2018 Mar 9.

PMID:
29530493
8.

Why do endocrine profiles in elite athletes differ between sports?

Sönksen PH, Holt RIG, Böhning W, Guha N, Cowan DA, Bartlett C, Böhning D.

Clin Diabetes Endocrinol. 2018 Feb 7;4:3. doi: 10.1186/s40842-017-0050-3. eCollection 2018.

9.

Hyperandrogenism controversy in elite women's sport: an examination and critique of recent evidence.

Sőnksen PH, Bavington LD, Boehning T, Cowan D, Guha N, Holt R, Karkazis K, Ferguson-Smith MA, Mircetic J, Bőhning D.

Br J Sports Med. 2018 Dec;52(23):1481-1482. doi: 10.1136/bjsports-2017-098446. Epub 2018 Jan 19. No abstract available.

PMID:
29351951
10.

Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detection.

Böhning D, Liu W, Holt RI, Böhning W, Guha N, Sönksen P, Cowan D, Liang T.

Stat Methods Med Res. 2017 Jan 1:962280217739452. doi: 10.1177/0962280217739452. [Epub ahead of print]

PMID:
29145769
11.

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.

Newsome PN, Fox R, King AL, Barton D, Than NN, Moore J, Corbett C, Townsend S, Thomas J, Guo K, Hull D, Beard HA, Thompson J, Atkinson A, Bienek C, McGowan N, Guha N, Campbell J, Hollyman D, Stocken D, Yap C, Forbes SJ.

Lancet Gastroenterol Hepatol. 2018 Jan;3(1):25-36. doi: 10.1016/S2468-1253(17)30326-6. Epub 2017 Nov 7.

12.

Carcinogenicity of benzene.

Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Vilahur N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2017 Dec;18(12):1574-1575. doi: 10.1016/S1470-2045(17)30832-X. Epub 2017 Oct 26. No abstract available.

PMID:
29107678
13.

Isolated aortic root dilation in homocystinuria.

Lorenzini M, Guha N, Davison JE, Pitcher A, Pandya B, Kemp H, Lachmann R, Elliott PM, Murphy E.

J Inherit Metab Dis. 2018 Jan;41(1):109-115. doi: 10.1007/s10545-017-0094-7. Epub 2017 Oct 4.

14.

Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice.

Morovat A, Weerasinghe G, Nesbitt V, Hofer M, Agnew T, Quaghebeur G, Sergeant K, Fratter C, Guha N, Mirzazadeh M, Poulton J.

J Clin Med. 2017 Aug 21;6(8). pii: E80. doi: 10.3390/jcm6080080.

15.

Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.

Fang P, Jiang W, Allen P, Glitza I, Guha N, Hwu P, Ghia A, Phan J, Mahajan A, Tawbi H, Li J.

J Neurooncol. 2017 Jul;133(3):595-602. doi: 10.1007/s11060-017-2470-4. Epub 2017 May 12.

PMID:
28500560
16.

Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide.

Guha N, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Vilahur N, Muller K, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2017 May;18(5):581-582. doi: 10.1016/S1470-2045(17)30255-3. Epub 2017 Apr 10. No abstract available.

PMID:
28408286
17.

Erratum to: Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.

Böhning D, Böhning W, Guha N, Cowan DA, Sönksen PH, Holt RI.

BMC Med Res Methodol. 2016 Nov 28;16(1):164. No abstract available.

18.

MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.

Zhang L, Wang J, Wang Y, Zhang Y, Castro P, Shao L, Sreekumar A, Putluri N, Guha N, Deepak S, Padmanaban A, Creighton CJ, Ittmann M.

Cancer Res. 2016 Nov 1;76(21):6290-6298. Epub 2016 Aug 30.

19.

Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.

Böhning D, Böhning W, Guha N, Cowan DA, Sönksen PH, Holt RI.

BMC Med Res Methodol. 2016 Oct 28;16(1):147. Erratum in: BMC Med Res Methodol. 2016 Nov 28;16(1):164.

20.

Carcinogenicity of pentachlorophenol and some related compounds.

Guyton KZ, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2016 Dec;17(12):1637-1638. doi: 10.1016/S1470-2045(16)30513-7. Epub 2016 Oct 23. No abstract available. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711.

PMID:
27784619
21.

Therapeutic drug monitoring in the era of precision medicine: opportunities!

Cremers S, Guha N, Shine B.

Br J Clin Pharmacol. 2016 Oct;82(4):900-2. doi: 10.1111/bcp.13047. No abstract available.

22.

Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps.

Cichocki JA, Guyton KZ, Guha N, Chiu WA, Rusyn I, Lash LH.

J Pharmacol Exp Ther. 2016 Oct;359(1):110-23. doi: 10.1124/jpet.116.232629. Epub 2016 Aug 10. Review.

23.

Carcinogenicity of drinking coffee, mate, and very hot beverages.

Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2016 Jul;17(7):877-878. doi: 10.1016/S1470-2045(16)30239-X. Epub 2016 Jun 15. No abstract available.

PMID:
27318851
24.

Prioritizing Chemicals for Risk Assessment Using Chemoinformatics: Examples from the IARC Monographs on Pesticides.

Guha N, Guyton KZ, Loomis D, Barupal DK.

Environ Health Perspect. 2016 Dec;124(12):1823-1829. Epub 2016 May 10.

25.

Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.

Holt RI, Guha N, Böhning W, Bartlett C, Cowan DA, Sönksen PH, Böhning D.

Drug Test Anal. 2017 Jan;9(1):30-37. doi: 10.1002/dta.1941. Epub 2016 Feb 17.

PMID:
26888146
26.

Earlier Detection And Treatment of Non-Alcoholic Fatty Liver Disease: An Economic Evaluation to Appraise An Innovative Diagnostic Pathway to Detect And Intervene Where There Are Known Risk Factors.

Tanajewski L, Harris R, Harman D, Guha N, Gkountouras G, Berdunov V, Elliott RA.

Value Health. 2015 Nov;18(7):A627. doi: 10.1016/j.jval.2015.09.2208. Epub 2015 Oct 20. No abstract available.

27.

Carcinogenicity of consumption of red and processed meat.

Bouvard V, Loomis D, Guyton KZ, Grosse Y, Ghissassi FE, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2015 Dec;16(16):1599-600. doi: 10.1016/S1470-2045(15)00444-1. Epub 2015 Oct 29. No abstract available.

PMID:
26514947
28.

Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.

Barkeer S, Guha N, Hothpet V, Saligrama Adavigowda D, Hegde P, Padmanaban A, Yu LG, Swamy BM, Inamdar SR.

Glycobiology. 2015 Dec;25(12):1375-91. doi: 10.1093/glycob/cwv067. Epub 2015 Sep 7.

PMID:
26347523
29.

Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides.

Schafer JL, Ries M, Guha N, Connole M, Colantonio AD, Wiertz EJ, Wilson NA, Kaur A, Evans DT.

PLoS Pathog. 2015 Sep 2;11(9):e1005145. doi: 10.1371/journal.ppat.1005145. eCollection 2015 Sep.

30.

European Code against Cancer, 4th Edition: Tobacco and cancer.

Leon ME, Peruga A, McNeill A, Kralikova E, Guha N, Minozzi S, Espina C, Schüz J.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S20-33. doi: 10.1016/j.canep.2015.06.001. Epub 2015 Aug 11.

31.

Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid.

Loomis D, Guyton K, Grosse Y, El Ghissasi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France.

Lancet Oncol. 2015 Aug;16(8):891-2. doi: 10.1016/S1470-2045(15)00081-9. Epub 2015 Jun 22. No abstract available.

PMID:
26111929
32.

Use of mechanistic data in the IARC evaluations of the carcinogenicity of polychlorinated biphenyls and related compounds.

Lauby-Secretan B, Loomis D, Baan R, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Grosse Y, Straif K.

Environ Sci Pollut Res Int. 2016 Feb;23(3):2220-9. doi: 10.1007/s11356-015-4829-4. Epub 2015 Jun 17. Review.

PMID:
26077316
33.

The Effects of Recombinant Human Insulin-Like Growth Factor-I/Insulin-Like Growth Factor Binding Protein-3 Administration on Body Composition and Physical Fitness in Recreational Athletes.

Guha N, Nevitt SP, Francis M, Woodland JA, Böhning D, Sönksen PH, Holt RI.

J Clin Endocrinol Metab. 2015 Aug;100(8):3126-31. doi: 10.1210/jc.2015-1996. Epub 2015 Jun 5.

PMID:
26046967
34.

Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate.

Guyton KZ, Loomis D, Grosse Y, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group, IARC, Lyon, France.

Lancet Oncol. 2015 May;16(5):490-1. doi: 10.1016/S1470-2045(15)70134-8. Epub 2015 Mar 20. No abstract available.

PMID:
25801782
35.

The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.

Holt RI, Böhning W, Guha N, Bartlett C, Cowan DA, Giraud S, Bassett EE, Sönksen PH, Böhning D.

Drug Test Anal. 2015 Sep;7(9):745-55. doi: 10.1002/dta.1772. Epub 2015 Jan 21.

PMID:
25645199
36.

Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes.

Grosse Y, Loomis D, Guyton KZ, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2014 Dec;15(13):1427-8. doi: 10.1016/S1470-2045(14)71109-X. Epub 2014 Oct 31. No abstract available.

PMID:
25499275
37.

Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane, and 1,3-propane sultone.

Benbrahim-Tallaa L, Lauby-Secretan B, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2014 Aug;15(9):924-5. No abstract available.

PMID:
25225686
38.

The carcinogenicity of outdoor air pollution.

Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group IARC.

Lancet Oncol. 2013 Dec;14(13):1262-3. No abstract available.

PMID:
25035875
39.

Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis.

Hamra GB, Guha N, Cohen A, Laden F, Raaschou-Nielsen O, Samet JM, Vineis P, Forastiere F, Saldiva P, Yorifuji T, Loomis D.

Environ Health Perspect. 2014 Sep;122(9):906-11. doi: 10.1289/ehp.1408092. Epub 2014 Jun 6. Review. Erratum in: Environ Health Perspect. 2014 Sep;122(9):A236.

40.

Tetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studies.

Vlaanderen J, Straif K, Ruder A, Blair A, Hansen J, Lynge E, Charbotel B, Loomis D, Kauppinen T, Kyyronen P, Pukkala E, Weiderpass E, Guha N.

Environ Health Perspect. 2014 Jul;122(7):661-6. doi: 10.1289/ehp.1307055. Epub 2014 Mar 21. Review.

41.

Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.

Guha N, Erotokritou-Mulligan I, Bartlett C, Nevitt SP, Francis M, Bassett EE, Cowan DA, Sönksen PH, Holt RI.

J Clin Endocrinol Metab. 2014 Jun;99(6):2259-68. doi: 10.1210/jc.2013-3897. Epub 2014 Feb 25.

PMID:
24606087
42.

Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control.

Guha N, Warnakulasuriya S, Vlaanderen J, Straif K.

Int J Cancer. 2014 Sep 15;135(6):1433-43. doi: 10.1002/ijc.28643. Epub 2014 May 14.

43.

Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.

Guha N, Erotokritou-Mulligan I, Nevitt SP, Francis M, Bartlett C, Cowan DA, Bassett EE, Sönksen PH, Holt RI.

Drug Test Anal. 2013 Nov-Dec;5(11-12):843-9. doi: 10.1002/dta.1562. Epub 2013 Oct 31.

PMID:
24173773
44.

Carcinogenicity of some drugs and herbal products.

Grosse Y, Loomis D, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2013 Aug;14(9):807-8. No abstract available.

PMID:
24058961
45.

Assays for GH, IGF-I, and IGF binding protein-3.

Guha N.

Methods Mol Biol. 2013;1065:117-28. doi: 10.1007/978-1-62703-616-0_7.

PMID:
23996360
46.

Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.

Guha N, Cowan DA, Sönksen PH, Holt RI.

Anal Bioanal Chem. 2013 Dec;405(30):9669-83. doi: 10.1007/s00216-013-7229-y. Epub 2013 Aug 11. Review.

PMID:
23934394
47.

Trans-jugular intrahepatic porto-systemic shunt placement for refractory ascites: a 'real-world' UK health economic evaluation.

Parker MJ, Guha N, Stedman B, Hacking N, Wright M.

Frontline Gastroenterol. 2013 Jul;4(3):182-186. doi: 10.1136/flgastro-2012-100283. Epub 2012 Mar 22.

48.

Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls.

Lauby-Secretan B, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K; WHO International Agency for Research on Cancer.

Lancet Oncol. 2013 Apr;14(4):287-8. doi: 10.1016/S1470-2045(13)70104-9. Epub 2013 Mar 15. No abstract available.

PMID:
23499544
49.

Nonparametric Bayesian methods for benchmark dose estimation.

Guha N, Roy A, Kopylev L, Fox J, Spassova M, White P.

Risk Anal. 2013 Sep;33(9):1608-19. doi: 10.1111/risa.12004. Epub 2013 Jan 22.

PMID:
23339666
50.

Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites.

Guha N, Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Baan R, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2012 Dec;13(12):1192-3. No abstract available.

PMID:
23323277

Supplemental Content

Support Center